53663-19-7 Usage
Uses
Used in Pharmaceutical Research:
2-(pyrrolidin-1-yl)propan-1-ol is used as a research chemical for studying the effects of psychoactive substances and their potential applications in medicine. Its structural similarity to other stimulant drugs allows researchers to explore its mechanisms of action and compare its effects with those of other compounds.
Used in Forensic Toxicology:
In forensic toxicology, 2-(pyrrolidin-1-yl)propan-1-ol is used as a reference compound for the identification and analysis of substances in biological samples. Its presence in samples can indicate the use of controlled substances and contribute to the investigation of drug-related crimes.
Used in Drug Policy and Regulation:
2-(pyrrolidin-1-yl)propan-1-ol serves as a case study for the development and implementation of drug policies and regulations. Its classification as a controlled substance and the legal restrictions surrounding its use provide insights into the challenges and considerations involved in managing the distribution and consumption of psychoactive substances.
Check Digit Verification of cas no
The CAS Registry Mumber 53663-19-7 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,3,6,6 and 3 respectively; the second part has 2 digits, 1 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 53663-19:
(7*5)+(6*3)+(5*6)+(4*6)+(3*3)+(2*1)+(1*9)=127
127 % 10 = 7
So 53663-19-7 is a valid CAS Registry Number.
53663-19-7Relevant academic research and scientific papers
FUSED 1,4-DIHYDRODIOXIN DERIVATIVES AS INHIBITORS OF HEAT SHOCK TRANSCRIPTION FACTOR 1
-
Paragraph 00105, (2015/04/22)
The present invention relates to compounds of formula I wherein A1, A2 R4 and Q are as defined herein. The compounds of the present invention are inhibitors of heat shock factor 1 (HSF1). In particular, the present invention relates to the use of these compounds as therapeutic agents for the treatment and/or prevention of proliferative diseases, such as cancer. The present invention also relates to processes for the preparation of these compounds, and to pharmaceutical compositions comprising them.
Diamino benzo[b]thiophene derivatives as a novel class of active site directed thrombin inhibitors: 3. Enhancing activity by imposing conformational restriction in the C-4'' side chain
Bastian, Jolie A.,Chirgadze, Nickolay,Denney, Michael L.,Gifford-Moore, Donetta S.,Sall, Daniel J.,Smith, Gerald F.,Wikel, James H.
, p. 363 - 368 (2007/10/03)
The preparation and biological evaluation of a series of benzo[b]thiophene diamine thrombin inhibitors possessing conformationally restricted C-4'' linkers are reported. Compared to the parent compounds 1a/b, the unsaturated derivatives 3a/b exhibited a m
